Obesity is a disease, and it reduces life span and compromises health. But given the expense to insurers, Dusetzina warned, if you expand the indications and extent of coverage, youll see premiums go up. For older patients, often underrepresented in clinical trials, questions about GLP-1s remain
PS: Conceptualization, Validation, Investigation, Supervision, Writing review and editing
For more information on safe bedsharing, you can find resources on the BASIS Baby Sleep Information Source website Treatments for Diabetes Treatments for Type 1 diabetes Insulin is the only treatment for controlling blood sugar levels in Type 1 diabetes
The difference between satisfied and full on semaglutide is the difference between a productive afternoon and three hours of nausea
In 2025, pharma companies are witnessing unprecedented growth in the obesity drug market, with GLP-1 receptor agonists leading the way
Significant Weight Reduction In Phase 2 clinical trials, Retatrutide showed record-breaking results, with some participants losing over 24% of their body weight over 48 weeks